Trial Profile
Phase II study of nonablative allogeneic blood stem cell transplantation for patients with lymphoid malignancies
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 Nov 2005
Price :
$35
*
At a glance
- Drugs Rituximab (Primary) ; Cyclophosphamide; Fludarabine
- Indications Haematological malignancies
- Focus Therapeutic Use
- 28 Nov 2005 New trial record.